Correlation Between Morningstar Unconstrained and Catalyst Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morningstar Unconstrained Allocation and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Morningstar Unconstrained and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and Catalyst Pharmaceuticals.

Diversification Opportunities for Morningstar Unconstrained and Catalyst Pharmaceuticals

0.5

Correlation Coefficient

Morningstar Unconstrained  Catalyst Pharmaceuticals

Very weak diversification

The 3 months correlation between Morningstar and Catalyst is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and Catalyst Pharmaceuticals go up and down completely randomly.

Pair Corralation between Morningstar Unconstrained and Catalyst Pharmaceuticals

Assuming the 90 days horizon Morningstar Unconstrained Allocation is expected to generate 0.34 times more return on investment than Catalyst Pharmaceuticals. However, Morningstar Unconstrained Allocation is 2.93 times less risky than Catalyst Pharmaceuticals. It trades about -0.22 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.31 per unit of risk. If you would invest  1,116  in Morningstar Unconstrained Allocation on March 20, 2024 and sell it today you would lose (31.00) from holding Morningstar Unconstrained Allocation or give up 2.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.24%
Values	Daily Returns

Morningstar Unconstrained Allo  vs.  Catalyst Pharmaceuticals

Morningstar Unconstrained

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Morningstar Unconstrained Allocation has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Morningstar Unconstrained is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Catalyst Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Catalyst Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Morningstar Unconstrained and Catalyst Pharmaceuticals

The main advantage of trading using opposite Morningstar Unconstrained and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.

The idea behind Morningstar Unconstrained Allocation and Catalyst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.